Methodological approach in adopting off-pump coronary artery bypass surgery in a British cardiothoracic unit:

Sharif Al-Ruzzeh1, Thanos Athanasiou, Shane George

  • 1The National Heart and Lung Institute, Imperial College of Science, Technology and Medicine, Harefield Hospital, Middlesex, United Kingdom.

Perfusion
|May 27, 2004
PubMed

Insights

Off-pump coronary artery bypass graft surgery is safe for all patients. This technique offers improved outcomes for patients with left ventricular dysfunction, women, and high-risk individuals.

Area of Science:

  • Cardiovascular Surgery
  • Cardiac Surgery Outcomes

Background:

  • Coronary artery bypass graft (CABG) surgery traditionally uses cardiopulmonary bypass with cardioplegic arrest, which has known disadvantages.
  • Off-pump CABG (OPCAB) has emerged as an alternative, with growing evidence supporting its benefits.

Purpose of the Study:

  • To validate the non-selective application of OPCAB in all patients.
  • To assess OPCAB outcomes in specific patient cohorts: those with ischemic left ventricular dysfunction, female patients, and high-risk individuals.
  • To investigate technical aspects of OPCAB, including mitral valve distortion effects and feasibility of sequential grafting.

Main Methods:

  • Retrospective data review and comparative analysis of outcomes at local and multi-center levels.
  • Risk-stratified comparison against national United Kingdom performance data.
  • Investigation of intraoperative hemodynamic stability related to mitral valve distortion during OPCAB.

Main Results:

  • Off-pump CABG was found to be feasible for all patient groups.
  • Improved outcomes were observed in patients with ischemic left ventricular dysfunction, female patients, and high-risk patients undergoing OPCAB.
  • Mitral valve distortion was identified as a contributor to intraoperative hemodynamic instability.

Conclusions:

  • Off-pump coronary artery bypass graft surgery is a safe and effective alternative to conventional CABG.
  • The OPCAB technique demonstrates superior outcomes in specific patient populations, including those with left ventricular dysfunction, women, and high-risk individuals.

Related Concept Videos